Successful control of subfulminant hepatitis related to lamivudine-resistant hepatitis B virus in an HIV-infected patient
- 1 December 2001
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 15 (18) , 2463-2464
- https://doi.org/10.1097/00002030-200112070-00020
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Interferon treatment with or without oral ganciclovir in HBeAg-negative chronic hepatitis B: a randomized study.Journal of Viral Hepatitis, 2000
- Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patientsHepatology, 1999
- Long-term ganciclovir therapy for hepatitis B virus infection after liver transplantationJournal of Hepatology, 1999
- Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapyHepatology, 1999
- Three Cases of Severe Subfulminant Hepatitis in Heart–Transplanted Patients After Nosocomial Transmission of A Mutant Hepatitis B VirusHepatology, 1999
- The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B: hepatitis B immune globulin escape, famciclovir non-response, followed by lamivudine resistance resulting in graft lossJournal of Hepatology, 1998
- An Algorithm for the Grading of Activity in Chronic Hepatitis CHepatology, 1996
- Ganciclovir treatment of hepatitis B virus infection in liver transplant recipientsHepatology, 1996
- INHIBITION OF HBV DNA REPLICATION BY GANCICLOVIR IN PATIENTS WITH AIDSThe Lancet, 1989